Skip to main content
Dr Cherry-Ann Waldron

Dr Cherry-Ann Waldron

Research Fellow / Senior Trial Manager

Email
waldronc@cardiff.ac.uk
Telephone
+44 (0)29 2068 7609
Campuses
702A, 7th Floor, Neuadd Meirionnydd, Heath Park
Users
Available for postgraduate supervision

Overview

I am a Research Fellow and Senior Trial Manager in the Infections, Inflammation & Immunity Research theme at the Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University.

My research interests include infections, vascular disease, surgical trials, behaviour change, public health and complex interventions.

I have extensive knowledge and experience in trial methodology and research governance.

Biography

Honours and awards

  • 2011: PhD (Medicine), Cardiff University.
  • Funded by Medical Research Council (Doctoral Training Grant).

    Thesis: Cardiovascular Risk Prediction: How useful are web-based tools and do risk representation formats matter?

  • 2006: BSc (Hons) Psychology, University of Wales Institute, Cardiff.

Professional memberships

Member of the UK Trial Managers’ Network (UK TMN).

British Psychological Society - Graduate Member and Division of Health Psychology Member.

Academic positions

2020-present - Research Fellow / Senior Trial Manager, Centre for Trials Research, Cardiff University.

2012-2020 - Research Associate / Trial Manager, Centre for Trials Research, Cardiff University.

2016-2017 - Research Associate / Trial Coordinator (secondment), School of Social and Community Medicine, University of Bristol.

2011-2012 - Research Assistant / Assistant Trial Manager, South East Wales Trials Unit, Cardiff University.

Publications

2020

2019

2018

2017

2016

2015

2013

2012

2011

2010

Research Interests

  • Infections, Inflammation and Immunity
  • Vascular Disease
  • Sepsis
  • Biomarkers
  • Antimicrobial stewardship
  • Surgical trials
  • Medical devices

I conduct evidence-based research testing the effectiveness of interventions with the aim of reducing antibiotic resistance. Also, improving the quality of evidence and innovation in surgery, medical devices and other complex interventions.

Grants

2020: NIHR Efficacy and Mechanism Evaluation (EME) programme - MR-PRo-adrenomedullin (MR-proADM) and ImmunoXpert Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness (PRECISE) study, (Co-Applicant) £385,450.

2020: Health and Care Research Wales RfPPB programme - PrEdiction of Risk and Communication of outcomE followIng major lower limb amputation - a collaboratiVE study (PERCEIVE), (Co-Applicant) £229,225.